Document is current
Any future updates will be listed below
-
Authors
Oh, Kyoung-Seok
Nam, Ah-Rong
Bang, Ju-Hee
Jeong, Yoojin
Choo, Sea Young
Kim, Hyo Jung
Lee, Su In
Kim, Jae-Min
Yoon, Jeesun
Kim, Tae-Yong
Oh, Do-Youn
- License Information
-
More Information
Article History
Received: 28 May 2024
Accepted: 13 October 2024
First Online: 24 October 2024
Declarations
:
: The study involving human PBMC collection and utilization was conducted following the Declaration of Helsinki and approved by the Seoul National University Hospital Institutional Review Board (IRB No. 1811–106-987). Informed consent was obtained from all the participants for the use of their human derivatives in the research.
: All participants in this study have provided consent to publish their data in accordance with ethical guidelines.
: Oh DY Consultant or advisory board member of AstraZeneca, Novartis, Genentech/Roche, Merck Serono, Bayer, Taiho, ASLAN, Halozyme, Zymeworks, BMS/Celgene, BeiGene, Basilea, Turning Point, and Yuhan. Research grant from AstraZeneca, Novartis, Array, Eli Lilly, Servier, BeiGene, MSD, and Handok. The other authors have no relevant financial or non-financial interests to disclose.
